Showing results (831-840 of 942) with videos related to

Sort By:
Pageof 95
Critical Care Medicine|April 16, 2021
The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network RegistryPatrick R Lawler, David D Berg, Jeong-Gun Park, et al.
JACC. Advances|August 21, 2025
Medical Intensive Care Unit Overflow Into the Cardiac Intensive Care Unit: Insights From CCCTN RegistryAmeesh Isath, Atul Bali, Uzair A Mahmood, et al.
Multiple Sclerosis and Related Disorders|February 9, 2025
Does cognitive performance explain the gap between physiological and perceived fall-risk in people with multiple sclerosis?Tobia Zanotto, Danya Pradeep Kumar, Daniel Golan, et al.
Journal of the American Heart Association|February 26, 2025
A Framework for Exception From Informed Consent in Trials Enrolling Patients With ST-Segment-Elevation Myocardial Infarction and Cardiogenic ShockGraham Nichol, Neal W Dickert, Jacob E Moeller, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 2, 2013
Smg1 haploinsufficiency predisposes to tumor formation and inflammationTara L Roberts, Uda Ho, John Luff, et al.
Journal of Cardiac Failure|August 17, 2025
Growth differentiation factor-15 and the effect of dapagliflozin in heart failure: insights from the DAPA-HF trialDavid D Berg, Kieran Docherty, Atefeh Talebi, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Eclinicalmedicine|August 25, 2020
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare systemCian P McCarthy, Sean Murphy, Maeve Jones-O'Connor, et al.
JAMA Network Open|May 3, 2021
Trends in Patient Characteristics and COVID-19 In-Hospital Mortality in the United States During the COVID-19 PandemicGregory A Roth, Sophia Emmons-Bell, Heather M Alger, et al.
Pageof 95